アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

Information

2023.10.3
Information Science Impact magazine published an article about the treatment for Hunner-type interstitial cystitis using TAGCyx’s aptamer, TAGX-0003.
2023.5.29
Information Announcing the renovating of TAGCyx website
2021.8.10
Information Pipeline is updated
2020.6.22
Information We updated in-house pipeline
2020.6.1
Information TAGCyx established an Audit & Supervisory Board
2020.5.28
Information Notice of New management team
2017.10.23
Information Oct 16th We have moved to Tokyo University Komaba campus.